Sabra Health Care REIT, Inc. (SBRA) स्टॉक विश्लेषण

कंपनी का अवलोकन

Sabra Health Care REIT, Inc. operates as a self-administered and self-managed real estate investment trust that owns and invests in real estate properties serving the healthcare industry throughout the United States and Canada. The company functions within the broader Real Estate sector, specifically categorized under the REIT - Healthcare Facilities industry, which focuses on acquiring and managing properties for medical and senior housing needs. Sabra Health Care REIT, Inc. demonstrates a significant scale with a market capitalization of $5.06B, annual revenue of $775.76M, and an employee base of 58 individuals. These valuation and revenue figures indicate that the company holds a substantial position in the healthcare real estate market, commanding a capitalization that reflects investor confidence in its asset portfolio despite a relatively lean workforce of 58 employees managing operations across the US and Canada.

वित्तीय स्वास्थ्य

The company generated revenue of $775.76M over the trailing twelve months, resulting in a net income of $155.61M and an EBITDA of $447.11M. The substantial gap between the $775.76M revenue and the $155.61M net income reveals a significant cost structure that includes operating expenses, interest costs, and taxes that reduce the bottom line by approximately 80% of gross sales. Sabra Health Care REIT, Inc. reported a free cash flow of $320.53M, which provides the organization with considerable financial flexibility to manage capital expenditures, service debt obligations, or pursue strategic acquisitions without relying solely on external financing. Profitability analysis shows a gross margin of 65.2%, indicating high revenue retention after direct costs, while an operating margin of 23.7% reflects efficient management of overhead and administrative functions. The profit margin stands at 20.1%, which measures the final percentage of revenue that translates into net earnings after all expenses are accounted for. Regarding liquidity and leverage, the company holds $74.92M in cash against total debt of $2.54B, resulting in a high debt-to-equity ratio of 89.86% that characterizes a highly leveraged balance sheet typical for REITs but requiring careful interest rate management. Short-term liquidity is supported by a current ratio of 1.80, indicating that the company possesses 1.80 times more current assets than current liabilities to meet immediate obligations. Return on equity is reported at 5.6% and return on assets at 3.1%, metrics that reveal the management's effectiveness in generating profits from shareholder capital and total assets, respectively, though these returns are moderate relative to the high leverage employed.

मूल्यांकन आकलन

The valuation metrics show a trailing P/E ratio of 31.38 and a forward P/E of 25.58, where the difference between these figures implies that the market expects earnings growth or a multiple compression in the future to align current prices with forward expectations. The price-to-book ratio is 1.79, which indicates that the stock trades at a premium of 79% above its book value, reflecting market pricing for the quality of its healthcare assets and future cash flow potential. Alternative valuation measures include a price-to-sales ratio of 6.53 and an EV/EBITDA of 16.84, suggesting that investors are willing to pay a significant multiple relative to both sales and operating earnings compared to broader industry peers. The 52-week high is $21.07 and the 52-week low is $15.75; without a specific current price provided in the facts, the valuation range defines the historical volatility over the past year for the SBRA ticker. The beta value is 0.65, which explains that the stock exhibits lower price volatility relative to the broader market, moving with roughly 35% less intensity than the overall equity market index.

Growth & Income

Revenue growth year-over-year is 15.8%, while earnings growth year-over-year is -44.7%, indicating that earnings are growing significantly slower than revenue, likely due to the high payout ratio or one-time expenses impacting the net income figure. As a dividend payer, the company offers a dividend yield of 6.0% with a payout ratio of 187.5%, which suggests that the dividend is not fully supported by current net income and relies on cash flow or retained earnings to maintain payments. This high payout ratio implies that the sustainability of the dividend is dependent on the strong free cash flow generation rather than accounting net income, as the company reinvests minimal earnings into growth while distributing the majority of its cash to shareholders. The overall growth and income profile presents a high-yield income strategy with moderate revenue expansion but a decoupling of earnings growth from top-line performance.